Akoustis Technologies (AKTS) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AKTS shares.
View AKTS analyst ratings or view top-rated stocks.

2 equities research analysts have issued twelve-month price objectives for Akoustis Technologies' stock. Their AKTS share price forecasts range from $1.75 to $7.00. On average, they predict the company's stock price to reach $3.92 in the next year. This suggests a possible upside of 407.5% from the stock's current price.
View analysts price targets for AKTS or view top-rated stocks among Wall Street analysts.

Akoustis Technologies' stock was trading at $2.82 at the start of the year. Since then, AKTS stock has decreased by 72.6% and is now trading at $0.7717.
View the best growth stocks for 2023 here.

Akoustis Technologies saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 7,220,000 shares, an increase of 9.7% from the August 15th total of 6,580,000 shares. Based on an average trading volume of 844,600 shares, the short-interest ratio is presently 8.5 days.
View Akoustis Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our AKTS earnings forecast.

Akoustis Technologies, Inc. (NASDAQ:AKTS) released its earnings results on Wednesday, September, 6th. The technology company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by $0.05. The technology company had revenue of $8.33 million for the quarter, compared to analysts' expectations of $8.40 million. Akoustis Technologies had a negative trailing twelve-month return on equity of 63.41% and a negative net margin of 234.35%. During the same quarter in the prior year, the company earned ($0.26) earnings per share.

Akoustis Technologies updated its first quarter 2024 earnings guidance on Thursday, September, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $7.08 million-$7.08 million, compared to the consensus revenue estimate of $7.66 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Block (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Akoustis Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.68%), Silverback Asset Management LLC (2.85%), Silverback Asset Management LLC (2.85%), Geode Capital Management LLC (1.98%), Sargent Investment Group LLC (1.91%) and Granahan Investment Management LLC (1.81%). Insiders that own company stock include Arthur Geiss, David Aichele, James Michael Mcguire, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends.

Shares of AKTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AKTS stock can currently be purchased for approximately $0.77.

Akoustis Technologies (NASDAQ:AKTS) has a market capitalization of $55.84 million and generates $27.12 million in revenue each year. The technology company earns $-63,560,000.00 in net income (profit) each year or ($1.00) on an earnings per share basis.

The company employs 205 workers across the globe.

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The official website for the company is www.akoustis.com. The technology company can be reached via phone at (704) 997-5735 or via email at bprag@delmarconsulting.com.